-
How Africa vaccine production would boost global adjuvants market
SHEM OIRERE
September 15, 2021
The drive to expand vaccine manufacturing in Africa is gaining momentum with several new partnership agreements including technology transfer for the production of both malaria and COVID-19 vaccine...
-
Will EXO-CD24, the New Drug from Israeli, Bring COVID-19 to an End?
PharmaSources/Big Cat in the Pharma Industry
August 25, 2021
Recently, the issue that Israeli medical staff obtained a new drug named EXO-CD24 with remarkable curative effect on COVID-19 infection are making a lot of headlines on domestic media.
-
A Review of the Three Chinese Patent Medicines Traditional Chinese Medicine to Treat COVID-19
PharmaSources/Miling
January 31, 2021
The Joint Prevention and Control Mechanism of the State Council of China has recently held a special press conference on the research progress of COVID-19 drug R&D and vaccine development, etc. According to the principal of the National Administration of
-
Which one of new dosage forms of nasal spray vaccine for COVID-19 will be successful?
PharmaSources/Big Cat of Medical Field
August 06, 2021
According to the latest news on March 24, 2021 (last week), CanSino (688185.SH, 06185.HK) inhaled COVID-19 vaccine was approved by the National Medical Products Administration.
-
India’s Pharmaceutical Industry Disruption Impacts Africa and the World
Shem Oirere
August 06, 2021
India is one of the top global pharmaceutical producing markets that a large share of the global healthcare systems relies on for supply of drug formulations and biologicals at least until COVID-19 pandemic struck.
-
New Progress of Potential "Specific Drugs" for COVID-19: Masitinib + S2H97
PharmaSources/Chuxin
August 02, 2021
Since the outbreak of COVID-19 at the end of 2019, it has spread all over the world. Up to now, more than 190 million confirmed cases of COVID-19 have been reported worldwide, and more than 4.11 million patients have died, causing great disasters.
-
Cocktail COVID-19 Neutralizing Antibody was Officially Approved in Japan to Build a Second Line of Defense
PharmaSources/Xiaoyaowan
August 02, 2021
Recently, Ronapreve, a product of Roche Pharmaceuticals, was approved by the Japanese Ministry of Health, Labour and Welfare for the treatment of mild to moderate COVID-19 patients by intravenous infusion.
-
Covid-19 Oral Medicine -- a Link to be focused on Against Epidemic
PharmaSources/Chuxin
July 26, 2021
In the wake of the outbreak of the COVID-19, the globally cumulative infected population has capped 100 million, which poses a huge impact on human activities.
-
Boost for Africa’s APIs Production Plan
Shem Oirere
July 13, 2021
The raging COVID-19 pandemic has not only confirmed how interdependent the global pharmaceutical industry is but also exposed the danger in Africa’s heavy reliance on pharmaceutical product imports hence mounting pressure on governments in the region.
-
What are the benefits of COVID-19 vaccine?
PharmaSources/Big Cat of Medical Field
June 17, 2021
When it comes to the benefits of vaccines, the first thing we are going to talk about is the stem of the vaccines - influenza virus.